🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +17.99% on $BVS in just 19h 7m.
MTN
$MTNB
🔒 US EquitiesMatinas BioPharma Holdings Inc
AVG HISTORICAL GAP
-5.82%
MAX GAP RECORD
-32.73%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $MTNB
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$MTNB
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 12, 2026 Earnings Release 2026-08-12 (UNDETERMINED) |
+0.00%
|
| Aug 13, 2025 Earnings Release 2025-08-13 (AFTER CLOSE) |
-1.28%
|
| Apr 15, 2025 Earnings Release 2025-04-15 (AFTER CLOSE) |
-1.72%
|
| Nov 13, 2024 Earnings Release 2024-11-13 (AFTER CLOSE) |
-5.21%
|
| Aug 14, 2024 Earnings Release 2024-08-14 (AFTER CLOSE) |
+0.64%
|
| May 10, 2024 Earnings Release 2024-05-10 (AFTER CLOSE) |
+1.14%
|
| Nov 08, 2023 Earnings Release 2023-11-08 (AFTER CLOSE) |
+1.09%
|
| Aug 09, 2023 Earnings Release 2023-08-09 (AFTER CLOSE) |
-32.73%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
7.6%
Bullish Gaps (3)
Bearish Gaps (5)
Neutral / Flat (1)
📖 Intelligence Summary
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗